Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
doctor with overweight patient who may be treated with TAVR or surgery

Are GLP-1 agonists safe? FDA finds no evidence popular weight loss medications cause suicidal thoughts or actions

The popular drugs, originally developed to treat diabetes, are being used more and more in the United States to help obese and overweight patients lose weight.  

hospitals healthcare cybersecurity

Binding cybersecurity standards are close at hand for healthcare

Hospitals that want to remain eligible for federal dollars—including CMS reimbursement—will soon need to show their cybersecurity is up to snuff.

general lloyd austin hospitalization

Behind Gen. Austin’s controversially quiet ICU stay

Word is out on the elective procedure that started the secretive medical episode in the first place. 

hospital price transparency

US healthcare enters 2024 with transparency momentum to build on

Both providers and payers upped their game on price transparency in 2023.

Money bankruptcy debt liquidation

Cardiologists make a familiar plea, urging Congress to eliminate impending Medicare cuts

Congress has already adjourned for the year without taking action, but U.S. medical societies are hoping relief from significant Medicare cuts will arrive in early 2024. 

covid PPE surplus

COVID protective gear expires, piles up—and goes to waste

What happens when hospitals en masse stock up on supplies to withstand a health crisis of unknown duration?

Peter Moffatt, RBMA president-elect, discusses biggest issues facing radiology practices at RSNA 2023. #RBMA #RSNA #Radiology #CMScuts

Navigating the crucial challenges in radiology practice management

RBMA President-elect Pete Moffatt discusses how to contend with challenges such as staff shortages and reimbursement issues.

maya kowalski johns hopkins trial

Did ‘Maya’ juror call Hopkins witness a Nazi—or did Hopkins lawyers smear a good juror?

To their reasons for seeking a retrial in the Maya Kowalski case, attorneys for Johns Hopkins All Children’s Hospital in Florida have added a juror’s possibly mischievous and bias-revealing courtroom notes.

Displaying 273 - 280 of 2769

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup